Who owns ENTERO THERAPEUTICS INC?
- Ticker: GRDX
- CUSIP Number: 33749p507
Tip: Access positions for across all investors
Analyze quarterly positions in Entero Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Entero Therapeutics stock
Who bought or sold ENTERO THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Federation des caisses Desjardins du Quebec | 48k | $97k | 100% | Mar 2026 |
|
| Geode Capital Management | 33k | $67k | 63% | Mar 2026 |
|
| Renaissance Technologies | 31k | $145k | -64% | Dec 2025 |
|
| State Street Corporation | 23k | $109k | 21% | Dec 2025 |
|
| Vanguard Group | 22k | $101k | 0% | Dec 2025 |
|
| Vanguard Capital Management | 18k | $37k | 100% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 16k | $33k | 100% | Mar 2026 |
|
| Jane Street | 13k | $26k | 100% | Mar 2026 |
|
| Harbour Investments | 8.0k | $16k | 100% | Mar 2026 |
|
| UBS Group | 3.2k | $6.4k | 495% | Mar 2026 |
|
| SBI Securities | 504.00 | $1.0k | 0% | Mar 2026 |
|
| Advisor Group Holdings | 1.00 | $4.000000 | 100% | Dec 2025 |
|
| Danske Bank A/s | 1.00 | $2.000000 | 0% | Mar 2026 |
|
| Citigroup | 1.00 | $2.000000 | 100% | Mar 2026 |
|
Who sold out of Entero Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| DRW Holdings | Dec 2025 | 49k | $227k |
| FNY Investment Advisers | Dec 2025 | 28k | $128k |
| Virtu Financial | Sep 2025 | 12k | $59k |